MarketWatch
Analyze & Strategize
Top News
Why are Paint Stocks Trading High Today? Asian Paints Leaps Over 4% – Investing.com India
The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases. Read More
reported by Investing.com at Investing.com
Shiba Inu hits another all-time-high — now more valuable than Adani Enterprises, Tata Steel and Tech Mahindra – Business Insider India
Meme coin Shiba Inu has hit another all-time high of $0.0000593 today, October 27, with its value skyrocketing by over 40% in the last 24 hours.After more Read More
reported by Prabhjote Gill at Business Insider India
Oil drops 1% as US stockpile rise saps rally By Reuters – Investing.com
Explained: Sequoia Capital’s new disruptive structure. What has prompted it? – Moneycontrol
Sequoia Capital, the world?s oldest venture capital firm, is disrupting its own business model so it can stay relevant in an era of intense competition. Moneycontrol explains the attempt Read More
reported by at Moneycontrol
Meet the most robust App for smartest Traders
Analyze.
Strategize.
Stay Ahead,
Always.
Downloads
From the blogs
Has Moody’s rated India fairly visvis peers? – Moneycontrol.com
Even if calendar year growth of 8.8 percent and 8.3 percent are considered, India would still be the fastest-growing economy. India?s adequacy of foreign exchange reserves should be the least of the worries for credit rating agencies. Read More reported by at...
This is Why Bharat Biotech’s Covaxin Failed to be the Hero of India’s Vaccination Story Against Covid News18
Complex processes, scattered production units, need for more safety zones and shortage of skilled staffers are some of the top reasons that restricted Bharat Biotech?s Covaxin from becoming the poster-boy of India?s vaccination story against Covid-19. Read More...
Biocon Biologics gets license to manufacture antibody treatment for Covid Hindustan Times
US-based Adagio Therapeutics has allowed the company to manufacture and commericalise the ADG20-based treatment in India, as well as in select markets. | Latest News India Read More reported by hindustantimes.com at Hindustan...